Emily M Le

Array ( [id] => 7020041 [patent_doc_number] => 20050222060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs' [patent_app_type] => utility [patent_app_number] => 10/507942 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19239 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222060.pdf [firstpage_image] =>[orig_patent_app_number] => 10507942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727491 [patent_doc_number] => 20060058251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods for treating and preventing infectious disease' [patent_app_type] => utility [patent_app_number] => 10/382822 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27288 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058251.pdf [firstpage_image] =>[orig_patent_app_number] => 10382822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835195 [patent_doc_number] => 20030162741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Oral DNA composition for hepatitis B virus chronic infection' [patent_app_type] => new [patent_app_number] => 10/375143 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24360 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162741.pdf [firstpage_image] =>[orig_patent_app_number] => 10375143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388963 [patent_doc_number] => 20040030118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Methods for regulating hematopoiesis using CpG-oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/373381 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26444 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030118.pdf [firstpage_image] =>[orig_patent_app_number] => 10373381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253302 [patent_doc_number] => 20070134758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/504249 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12033 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134758.pdf [firstpage_image] =>[orig_patent_app_number] => 10504249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367435 [patent_doc_number] => 20040092468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Immunostimulatory oligonucleotides with modified bases and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/365678 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13766 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092468.pdf [firstpage_image] =>[orig_patent_app_number] => 10365678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796903 [patent_doc_number] => 20030175777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Eleutherosides as adjuncts for vaccines and immune modulation' [patent_app_type] => new [patent_app_number] => 10/357913 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5012 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175777.pdf [firstpage_image] =>[orig_patent_app_number] => 10357913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770400 [patent_doc_number] => 20030216340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences' [patent_app_type] => new [patent_app_number] => 10/357760 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14827 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216340.pdf [firstpage_image] =>[orig_patent_app_number] => 10357760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6804624 [patent_doc_number] => 20030232018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Stabilized formulations of adenovirus' [patent_app_type] => new [patent_app_number] => 10/342344 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6376 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232018.pdf [firstpage_image] =>[orig_patent_app_number] => 10342344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951800 [patent_doc_number] => 20050226894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Oral vaccination' [patent_app_type] => utility [patent_app_number] => 10/501402 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2719 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226894.pdf [firstpage_image] =>[orig_patent_app_number] => 10501402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 662420 [patent_doc_number] => 07101676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA' [patent_app_type] => utility [patent_app_number] => 10/339217 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16163 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101676.pdf [firstpage_image] =>[orig_patent_app_number] => 10339217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643613 [patent_doc_number] => 20030104067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method of obtaining cellular immune responses from proteins' [patent_app_type] => new [patent_app_number] => 10/340034 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11125 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104067.pdf [firstpage_image] =>[orig_patent_app_number] => 10340034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 879340 [patent_doc_number] => 07354711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Methods for inhibiting immunostimulatory DNA associated responses' [patent_app_type] => utility [patent_app_number] => 10/336635 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9910 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354711.pdf [firstpage_image] =>[orig_patent_app_number] => 10336635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071764 [patent_doc_number] => 06841346 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-11 [patent_title] => 'Methods for detecting bacteriophage MS2' [patent_app_type] => utility [patent_app_number] => 10/328226 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7309 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841346.pdf [firstpage_image] =>[orig_patent_app_number] => 10328226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32601 [patent_doc_number] => 07785610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Chimeric immunomodulatory compounds and methods of using the same—III' [patent_app_type] => utility [patent_app_number] => 10/328578 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 66261 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785610.pdf [firstpage_image] =>[orig_patent_app_number] => 10328578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1076716 [patent_doc_number] => 07615227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Use of CpG oligodeoxynucleotides to induce angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/499597 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13027 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615227.pdf [firstpage_image] =>[orig_patent_app_number] => 10499597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855701 [patent_doc_number] => 20030129202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof' [patent_app_type] => new [patent_app_number] => 10/169668 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17406 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129202.pdf [firstpage_image] =>[orig_patent_app_number] => 10169668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394290 [patent_doc_number] => 20040038373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder' [patent_app_type] => new [patent_app_number] => 10/314869 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12768 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038373.pdf [firstpage_image] =>[orig_patent_app_number] => 10314869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865553 [patent_doc_number] => 20030191079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Methods for treating and preventing infectious disease' [patent_app_type] => new [patent_app_number] => 10/306522 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26950 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191079.pdf [firstpage_image] =>[orig_patent_app_number] => 10306522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822116 [patent_doc_number] => 20030220277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Methylation of plasmid vectors' [patent_app_type] => new [patent_app_number] => 10/291041 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15135 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220277.pdf [firstpage_image] =>[orig_patent_app_number] => 10291041 [rel_patent_id] =>[rel_patent_doc_number] =>)